The “Diabetes Comorbidome”: A Different Way for Health Professionals to Approach the Comorbidity Burden of Diabetes

Abstract

(1) Background: The disease burden related to diabetes is increasing greatly, particularly in older subjects. A more comprehensive approach towards the assessment and management of diabetes’ comorbidities is necessary. The aim of this study was to implement our previous data identifying and representing the prevalence of the comorbidities, their association with mortality, and the strength of their relationship in hospitalized elderly patients with diabetes, developing, at the same time, a new graphic representation model of the comorbidome called “Diabetes Comorbidome”. (2) Methods: Data were collected from the RePoSi register. Comorbidities, socio-demographic data, severity and comorbidity indexes (Cumulative Illness rating Scale CIRS-SI and CIRS-CI), and functional status (Barthel Index), were recorded. Mortality rates were assessed in hospital and 3 and 12 months after discharge. (3) Results: Of the 4714 hospitalized elderly patients, 1378 had diabetes. The comorbidities distribution showed that arterial hypertension (57.1%), ischemic heart disease (31.4%), chronic renal failure (28.8%), atrial fibrillation (25.6%), and COPD (22.7%), were the more frequent in subjects with diabetes. The graphic comorbidome showed that the strongest predictors of death at in hospital and at the 3-month follow-up were dementia and cancer. At the 1-year follow-up, cancer was the first comorbidity independently associated with mortality. (4) Conclusions: The “Diabetes Comorbidome” represents the perfect instrument for determining the prevalence of comorbidities and the strength of their relationship with risk of death, as well as the need for an effective treatment for improving clinical outcomes.

Health-Related Quality of Life Assessment in Older Patients with Type 1 and Type 2 Diabetes

“…Both T1D as well as T2D have detrimental effects on various health aspects including health-related quality of life (HRQOL) [3,4], with 24 healthy years of life lost per person Healthcare 2023, 11, 2154 2 of 14 with T1D [1]. HRQOL independently and more accurately predicts mortality in diabetic patients than some physiological diabetes-specific factors [5][6][7][8][9][10][11].…”

What Is the Role of Basal Weekly Insulin in Clinical Practice? The State of the Art

“…According to the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, diabetes was the eighth cause of death and disability globally [3]. Furthermore, the global burden of diabetes is predicted to increase among elderly patients due to reduced physical activity relating to T2DM mellitus, unhealthy diets, rising incidences of T1DM and the aging of the world population, determining a further surge in the hospitalization of subjects with diabetes and comorbidities, which are essential determinants of diabetes burden in terms of their considerable impact on a patient's quality of life, health status and outcomes [4,5]. In 2021, approximately 530 million adults worldwide were affected by diabetes [2], and 11.6% of the U.S. population (38.4 million people of all ages) had diabetes.…”

Physical Exercise and Occupational Therapy at Home to Improve the Quality of Life in Subjects Affected by Rheumatoid Arthritis: A Randomized Controlled Trial

“…For this reason, it requires a diagnostic approach and early intervention [10]. In this sense, the patient with RA is a complex patient that must be submitted to a multidisciplinary approach as in other diseases [11][12][13][14].…”